Antares Pharma CEO Paul Wotton is to resign his position to take over as CEO at development-stage biotech company Advanced Cell Technology.
Wotton spent nearly six years in charge of New Jersey-based Antares, having previously served as CEO of Topigen Pharmaceutical.
His replacement at Antares is Eamonn Hobbs, a current board member of the company. He has over 30 years of experience in the pharma and medical device sectors.
Hobbs was most recently president and CEO of Delcath Systems, a pharma and medical device company specialising in cancer treatment.
“We have worked closely with Eamonn over the past five years as board members and share his vision for the future,” said Leonard Jacob, chairman of the board of directors.